The Effect of Aerobic-resistance Training and Caloric Restriction on Hepatokine Factors Alterations in Obese Women with Non-alcoholic Fatty Liver Disease

Document Type : Research Article

Authors

Department of Exercise Physiology, Il.C., Islamic Azad University, Ilam, Iran

Abstract

Background: Factors secreted from hepatocytes, such as hepatokines, play a role in regulating intra and extrahepatic metabolic processes. The aim of this study was to investigate the effect of combined aerobic-resistance training (CT) and calorie restriction (CR) on hepatokines alteration in women with non-alcoholic fatty liver (NAFL) disease.
Methods: This quasi-experimental study was carried out using a pretest-posttest design in Ilam, Iran during the spring of 2023. A convenience sample of 37 participants was selected and randomly divided to one of four groups: control, CR, CT and CR+CT. The CT program was performed for eight weeks and three sessions per week. The CR groups, alleviate 400- 500 kcal/day from total daily calorie intake. Fatty liver was measured by ultrasound. Serum level of leukocyte-derived chemotaxin 2 (LECT2), angiopoietin-dependent growth factor (AGF) and sex hormone-binding globulin (SHBG) were measured in pre- and postintervention. Analysis of covariance (ANCOVA) and Bonferroni post hoc test were used to analyze between-group alterations.
Results: After CT and CR+CT, LECT2 (P=0.011, P=0.006, respectively) and AGF (P=0.041, P=0.032, respectively) level significantly decreased than the control group, and in CR group decreased compared with the pre-intervention (P=0.037, P=0.018, respectively). Also, SHBG level in the CT and CR+CT groups significantly increased than the control group (P=0.013, P=0.006, respectively), and in CR group increased than the pre-intervention (P=0.004).
Conclusions: CR has limited effects on the level of hepatokines in obese women with NAFL disease. In order to create favorable alterations in the level of hepatokines, this intervention should be implemented with CT.

Highlights

Abdolhossein Taheri Kalani: (Google Scholar)

 

How to Cite: Hayati M, Fatahi F, Taheri Kalani A. The Effect of Aerobic-resistance Training and Caloric Restriction on Hepatokine Factors Alterations in Obese Women with Non-alcoholic Fatty Liver Disease. Women. Health. Bull. 2025;12(3):170-179. doi: 10.30476/whb.2025.105828.1337.

Keywords

References

  1. Khan MS, Lee C, Kim SG. Non-alcoholic fatty liver disease and liver secretome. Arch Pharm Res. 2022;45(12):938-63. doi:10.1007/s12272-022-01419-w. PubMed PMID: 36441472; PubMed Central PMCID: PMC9703441. ##
  2. Shephard RJ, Johnson N. Effects of physical activity upon the liver. Eur J Appl Physiol. 2015;115(1):1-46. doi: 10.1007/s00421-014-3031-6. PubMed PMID: 25366252. ##
  3. Menendez A, Wanczyk H, Walker J, Zhou B, Santos M, Finck C. Obesity and adipose tissue dysfunction: from pediatrics to adults. Genes. 2022;13(10):1866. doi: 10.3390/genes13101866. PubMed PMID: 36292751; PubMed Central PMCID: PMC9601855. ##
  4. Lebensztejn DM, Flisiak-Jackiewicz M, Białokoz-Kalinowska I, Bobrus-Chociej A, Kowalska I. Hepatokines and non-alcoholic fatty liver disease. Acta Biochim Pol. 2016;63(3):459-67. doi:10.18388/abp.2016_1252. PubMed PMID: 27262842. ##
  5. Jensen-Cody SO, Potthoff MJ. Hepatokines and metabolism: Deciphering communication from the liver. Mol Metab. 2021;44:101138. doi: 10.1016/j.molmet.2020.101138. PubMed PMID: 33285302; PubMed Central PMCID: PMC7788242. ##
  6. Kim TH, Hong DG, Yang YM. Hepatokines and non-alcoholic fatty liver disease: Linking liver pathophysiology to metabolism. Biomedicines. 2021;9(12):1903. doi: 10.3390/biomedicines9121903. PubMed PMID: 34944728; PubMed Central PMCID: PMC8698516. ##
  7. Le S, Xu L, Schumann M, Wu N, Törmäkangas T, Alén M, Cheng S, Wiklund P. Does sex hormone-binding globulin cause insulin resistance during pubertal growth? Endocr Connect. 2019;8(5):510-17. doi: 10.1530/EC-19-0044. PubMed PMID: 30925463; PubMed Central PMCID: PMC6499923. ##
  8. Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, et al. Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin Gastroenterol Hepatol. 2015;13(9):1686-93. doi: 10.1016/j.cgh.2014.12.033. PubMed PMID: 25592661; PubMed Central PMCID: PMC4500744. ##
  9. Luo J, Chen Q, Shen T, Wang X, Fang W, Wu X, et al. Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2018;15:79. doi: 10.1186/s12986-018-0313-8. PubMed PMID: 30455723; PubMed Central PMCID: PMC6225668. ##
  10. Arefhosseini S, Ebrahimi-Mameghani M, Najafipour F, Tutunchi H. Non-alcoholic fatty liver disease across endocrinopathies: interaction with sex hormones. Front Endocrinol (Lausanne). 2022;13:1032361. doi: 10.3389/fendo.2022.1032361. PubMed PMID: 36419770; PubMed Central PMCID: PMC9676462. ##
  11. Zhang X, Mou Y, Aribas E, Amiri M, Nano J, Bramer WM, et al. Associations of sex steroids and sex hormone-binding globulin with non-alcoholic fatty liver disease: A Population-based study and meta-analysis. genes (Basel). 2022;13(6):966. doi: 10.3390/genes13060966. PubMed PMID: 35741728; PubMed Central PMCID: PMC9223113. ##
  12. Namkung J, Sohn JH, Chang JS, Park SW, Kim JY, Koh SB, et al. Increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study. Diabetes Metab J. 2019;43(4):521-29. doi: 10.4093/dmj.2018.0080. PubMed PMID: 30968619; PubMed Central PMCID: PMC6712233. ##
  13. Kim JH. Letter: Increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study. Diabetes Metab J. 2019;43(5):727-28. doi: 10.4093/dmj.2019.0172. PubMed PMID: 31694083; PubMed Central PMCID: PMC6834845. ##
  14. Xie Y, Fan KW, Guan SX, Hu Y, Gao Y, Zhou WJ. LECT2: A pleiotropic and promising hepatokine, from bench to bedside. J Cell Mol Med. 2022;26(13):3598-607. doi: 10.1111/jcmm.17407. PubMed PMID: 35656863; PubMed Central PMCID: PMC9258709. ##
  15. Willis SA, Sargeant JA, Yates T, Takamura T, Takayama H, Gupta V, et al. Acute hyperenergetic, high-fat feeding increases circulating FGF21, LECT2, and Fetuin-A in healthy men. J Nutr. 2020;150(5):1076-85. doi: 10.1093/jn/nxz333. PubMed PMID: 31919514. ##
  16. Zheng X, Lu J, Xiang S, Zou P, Chen H, Liu J, et al. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome. Acta Diabetol. 2024;61(5):643-55. doi: 10.1007/s00592-024-02242-z. PubMed PMID: 38383671. ##
  17. Wang J, Chen Y, Pan R, Wu C, Chen S, Li L, et al. Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice. Liver Int. 2021;41(4):777-87. doi: 10.1111/liv.14816. PubMed PMID: 33555112. ##
  18. Zhu S, Bennett S, Li Y, Liu M, Xu J. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases. J Cell Physiol. 2022;237(1):480-88. doi: 10.1002/jcp.30593. PubMed PMID: 34550600. ##
  19. Nath P, Panigrahi MK, Sahu MK, Narayan J, Sahoo RK, Patra AA, et al. Effect of exercise on NAFLD and its risk factors: Comparison of moderate versus low intensity exercise. J Clin Transl Hepatol. 2020;8(2):120-26. doi: 10.14218/JCTH.2019.00012. PubMed PMID: 32832391; PubMed Central PMCID: PMC7438352. ##
  20. Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22(1):63. doi: 10.1186/s12902-022-00980-1. PubMed PMID: 35287643; PubMed Central PMCID: PMC8919523. ##
  21. Sargeant JA, Gray LJ, Bodicoat DH, Willis SA, Stensel DJ, Nimmo MA, et al. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. Obes Rev. 2018;19(10):1446-59. doi: 10.1111/obr.12719.. PubMed PMID: 30092609. ##
  22. van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The effects of physical exercise on fatty liver disease. Gene Expr. 2018;18(2):89-101. doi: 10.3727/105221617X15124844266408. PubMed PMID: 29212576; PubMed Central PMCID: PMC5954622. ##
  23. Xue Y, Peng Y, Zhang L, Ba Y, Jin G, Liu G. Effect of different exercise modalities on nonalcoholic fatty liver disease: A systematic review and network meta-analysis. Sci Rep. 2024;14(1):6212. doi: 10.1038/s41598-024-51470-4. PubMed PMID: 38485714; PubMed Central PMCID: PMC10940706. ##
  24. Ghorbanian B, Saberi Y. The response of some hepatokines and insulin resistance to high intensity interval training in women with non-alcoholic fatty liver. J Appl Exer Physiol. 2020;16(32):57-71. doi: 10.22080/jaep.2020.19204.1959. Persian. ##
  25. Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. PubMed PMID: 34325496; PubMed Central PMCID: PMC8441096. ##
  26. Lough ME. Volume-based feeding in enteral nutrition: what about diabetes? Crit Care Nurse. 2017;37(4):76-77. doi: 10.4037/ccn2017143. PubMed PMID: 28765357. ##
  27. Saiedinejad E, Taheri Kalani A, Fatahi F. The effects of concurrent training and calorie restriction on anti-inflammatory adipokines and insulin sensitivity in obese women with fatty liver. Daneshvar Med. 2023;31(2):56-67. doi: 10.22070/daneshmed.2023.17509.1338. Persian. ##
  28. Hwang HJ, Jung TW, Kim BH, Hong HC, Seo JA, Kim SG, et al. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochem Pharmacol. 2015;98(1):157-66. doi: 10.1016/j.bcp.2015.08.098. PubMed PMID: 26297911. ##
  29. Yoo HJ, Hwang SY, Choi JH, Lee HJ, Chung HS, Seo JA, et al. Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis. PLoS One. 2017;12(4):e0174717. doi: 10.1371/journal.pone.0174717. PubMed PMID: 28376109; PubMed Central PMCID: PMC5380318. ##
  30. Tanimura Y, Aoi W, Takanami Y, Kawai Y, Mizushima K, Naito Y, et al. Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation. Physiol Rep. 2016;4(12):e12828. doi: 10.14814/phy2.12828. PubMed PMID: 27335433; PubMed Central PMCID: PMC4923231. ##
  31. Takata N, Ishii KA, Takayama H, Nagashimada M, Kamoshita K, Tanaka T, et al. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH. Sci Rep. 2021;11(1):555. doi: 10.1038/s41598-020-80689-0. PubMed PMID: 33436955; PubMed Central PMCID: PMC7804418. ##
  32. Ingerslev B, Hansen JS, Hoffmann C, Clemmesen JO, Secher NH, Scheler M, et al. Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP. Mol Metab. 2017;6(10):1286-95. doi: 10.1016/j.molmet.2017.06.018. PubMed PMID: 29031727; PubMed Central PMCID: PMC5641605. ##
  33. Singh AK, Chaube B, Zhang X, Sun J, Citrin KM, Canfrán-Duque A, et al. Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice. J Clin Invest. 2021;131(17):e140989. doi: 10.1172/JCI140989. PubMed PMID: 34255741; PubMed Central PMCID: PMC8409581. ##
  34. Janssen AWF, Katiraei S, Bartosinska B, Eberhard D, Willems van Dijk K, Kersten S. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota. Diabetologia. 2018;61(6):1447-58. doi: 10.1007/s00125-018-4583-5. PubMed PMID: 29502266; PubMed Central PMCID: PMC6449003. ##
  35. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, Hesselink MK, et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol. 2009;29(6):969-74. doi: 10.1161/ATVBAHA.108.182147. PubMed PMID: 19342599. ##
  36. Brianso-Llort L, Saéz-Lopez C, Alvarez-Guaita A, Ramos-Perez L, Hernandez C, Simó R, et al. Recent advances on sex hormone-binding globulin regulation by nutritional factors: clinical implications. Mol Nutr Food Res. 2024;68(14):e2400020. doi: 10.1002/mnfr.202400020. PubMed PMID: 38934352. ##
  37. Kim JW, Kim DY. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women. Metab Syndr Relat Disord. 2012;10(6):452-7. doi: 10.1089/met.2012.0036. PubMed PMID: 22989086. ##
  38. van Gemert WA, Schuit AJ, van der Palen J, May AM, Iestra JA, Wittink H, et al. Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial. Breast Cancer Res. 2015;17(1):120. doi: 10.1186/s13058-015-0633-9. PubMed PMID: 26330303; PubMed Central PMCID: PMC4557857. ##
  39. Briansó-Llort L, Fuertes-Rioja L, Ramos-Perez L, Hernandez C, Simó R, Selva DM. Caffeine upregulates hepatic sex hormone-binding globulin production by increasing adiponectin through AKT/FOXO1 pathway in white adipose tissue. Mol Nutr Food Res. 2020;64(17):e1901253. doi: 10.1002/mnfr.201901253. PubMed PMID: 32652892. ##
  40. Khorshidi D, Sarmadiyan M, Khoramjah M. Effect of aerobic- strength training on sex hormone binding globulin and some obesity indices in overweight and obese postmenopausal women. IJBD. 2016;9(1):14-20. Persian. ##

Files

Share

How to cite

Statistics